TMEM114

Transmembrane protein 114 B3SHH9 TM114_HUMAN
Protein Coding Chr 16 16p13.2 Swiss-Prot reviewed Entrez 283953
Mutations
77
CL 14 · Tissue 63
Samples
37
CL 12 · Tissue 25
Peptides
31
unique mutant peptides
Transcripts
3
isoforms mutated

Stats by Source

Total, split by cell line (COSMIC CL / DepMap / PubMed) vs tissue (COSMIC primary tissue)

How the counts split by source
Stats by Source

Total = all mutations for this gene across every source.

Cell line = COSMIC Cell Lines Project + DepMap + PubMed.

Tissue = COSMIC primary-tissue (patient tumour) samples.

Total can exceed cell line + tissue: COSMIC tissue-derived models sit only in global, and a peptide can be shared across both.

TotalCell lineTissue
Mutations771463
Samples371225
Peptides311120

Function

TMEM114 · Transmembrane protein 114

This gene encodes a glycosylated transmembrane protein that plays a role in lens and eye development. Mutations in this gene, including a t(16;22)(p13.3;q11.2) translocation, are associated with congenital and juvenile cataract disorders. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Feb 2014].

Isoforms & Proteins

3 transcripts · UniProt mapping is sequence-verified (AA-safe)

About the isoform mapping
Isoforms & Proteins

Each Ensembl transcript (ENST) this gene is mutated on, with its matched UniProt accession.

The mapping is sequence-verified: the UniProt sequence is identical to the transcript translation, so amino-acid positions line up exactly. A * marks an unreviewed (TrEMBL) entry.

Counts are mutations and unique mutant peptides on each transcript.

TranscriptUniProtMutationsPeptides
ENST00000620492 B3SHH9 37 29
ENST00000568335 H3BM71* 27 19
ENST00000624696 A0A096LNY9* 13 9

Gene Properties

Type
Protein Coding
Chromosome
16
Cytoband
16p13.2
Entrez ID

Recurrent Mutations

All 29 amino-acid changes on canonical ENST00000620492 · needle height = samples · drag the mini-map to zoom

What this lollipop shows
Recurrent Mutations

A lollipop / needle plot – the standard way to show recurrent mutations along a protein (as used by cBioPortal and MutationMapper).

X-axis = amino-acid position in the protein.

Needle height & head size = how often that exact amino-acid change was observed (its recurrence). Tall/large heads are mutational hotspots.

The most recurrent changes are labelled; hover any needle for the change, position and counts.

Mutation frequency across cancer types

% of samples with a missense/complex mutation in TMEM114 · cell line vs tissue

How this frequency is counted
Cancer-type mutation frequency

For each cancer type, the fraction of samples that carry at least one missense/complex mutation anywhere in TMEM114 – counted as distinct samples (a sample counts once no matter how many mutations it has).

Split into cell line and tissue; each cell shows mutated / total and the percentage. Cohorts with <20 samples are omitted. Ordered by combined frequency.

Cancer typeCell linesTissue samples
Rhabdomyosarcoma
0/33 0%
3/171 2%
Melanoma
5/210 2%
4/1899 0%
Non-Cancerous
0/104 0%
3/830 0%
Endometrial Carcinoma
1/42 2%
1/612 0%
Bladder Carcinoma
0/58 0%
3/956 0%
Neuroendocrine Tumour
0/154 0%
1/577 0%
Small Cell Lung Carcinoma
0/9 0%
1/752 0%
Squamous Cell Lung Carcinoma
1/57 2%
0/810 0%
Colorectal Carcinoma
0/143 0%
4/3239 0%
Biliary Tract Carcinoma
0/54 0%
1/950 0%
Ovarian Carcinoma
1/109 1%
0/998 0%
Glioma
1/52 2%
1/2127 0%
Pancreatic Carcinoma
1/89 1%
0/1611 0%
Thyroid Gland Carcinoma
0/45 0%
1/1592 0%
Gastric Carcinoma
0/74 0%
1/1809 0%
B-Lymphoblastic Leukemia
1/55 2%
0/2640 0%
Hepatocellular Carcinoma
0/46 0%
1/2210 0%
Breast Carcinoma
1/144 1%
0/3264 0%

Mutation Distribution

Where TMEM114 is mutated · all tissues, split by cell line vs tissue

Mutation counts by tissue
Mutation Distribution

How many mutations in TMEM114 were found in each tissue, across the whole database.

Each bar is a tissue (cell-line and tissue names are merged to the standard tissue), split into cell line and tissue (patient tumour) contributions.

This shows the cancer-context where this gene is recurrently altered.

GTEx Expression

Median TPM across 11 healthy tissues

GTEx Portal ↗
About the expression data
GTEx Expression

Median gene expression (TPM) in normal, non-cancer human tissues from the GTEx project.

Useful for judging tumour specificity – a strong neoantigen target ideally comes from a gene with low expression in healthy tissues.

Scroll or drag the mini-axis below the chart to browse all tissues.

Mutations

All 77 mutations in TMEM114

About the mutation list
Mutations

Every mutation record for this gene, across all samples and sources.

The Sample column links to the cell line (cell-line samples) or the tissue type (tissue samples).

Use the Type / Source filters, the search box, and column sorting to explore; each CAN-IMMUNE ID opens the full mutation & peptide view.

IDSampleTranscriptAA Change CDSTypeSourceMutant PeptideWild-type Peptide